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Abstract
Immune senescence, defined as the age-associated dysregulation and dysfunction of the immune system, is characterised
by impaired protective immunity and decreased efficacy of vaccines. Recent clinical, epidemiological and immunological
studies suggest that Cytomegalovirus (CMV) infection may be associated with accelerated immune senescence, possibly by
restricting the naı¨ve T cell repertoire. However, direct evidence whether and how CMV-infection is implicated in immune
senescence is still lacking. In this study, we have investigated whether latent mouse CMV (MCMV) infection with or without
thymectomy (Tx) alters antiviral immunity of young and aged mice. After infection with lymphocytic choriomeningitis virus
(LCMV) or Vaccinia virus, specific antiviral T cell responses were significantly reduced in old, old MCMV-infected and/or Tx
mice compared to young mice. Importantly, control of LCMV replication was more profoundly impaired in aged MCMV-
infected mice compared to age-matched MCMV-naı¨ve or young mice. In addition, latent MCMV infection was associated
with slightly reduced vaccination efficacy in old Tx mice. In contrast to the prevailing hypothesis of a CMV-mediated
restriction of the naı¨ve T cell repertoire, we found similar naı¨ve T cell numbers in MCMV-infected and non-infected mice,
whereas ageing and Tx clearly reduced the naı¨ve T cell pool. Instead, MCMV-infection expanded the total CD8+ T cell pool
by a massive accumulation of effector memory T cells. Based on these results, we propose a new model of increased
competition between CMV-specific memory T cells and any ‘de novo’ immune response in aged individuals. In summary,
our results directly demonstrate in a mouse model that latent CMV-infection impairs immunity in old age and propagates
immune senescence.
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Introduction
Immune senescence, defined as the age-related alterations of the
immune system, is associated with an increased incidence of
infections, cancer, autoimmunity and a reduced efficacy of
prophylactic vaccines [1–3]. Although all components of the
immune system undergo age-related changes, the T cell compart-
ment is most significantly affected by a quantitative and qualitative
loss of naı¨ve T cell diversity due to declining thymic output and
increasing dysregulation of compensatory homeostatic mecha-
nisms [4–8]. Therefore, ageing hosts have increasing difficulties to
mount efficient primary T cell responses whereas memory
maintenance and recall responses appear to be less affected [9–
11].
Immune senescence is certainly a multifactorial process
involving genetic, molecular, cellular and also environmental
factors. Among the latter, Cytomegalovirus (CMV) infection
has gained considerable interest in recent years as a potential
propagator of human immune senescence [12]. First, two
independent epidemiological studies have linked human
(H)CMV-seropositivity with decreased overall survival of
elderly [13,14]. Second, a series of Swedish cohort studies of
very elderly have identified a so called ‘immune risk profile’
(IRP), which was strongly predictive of all cause mortality.
Importantly, HCMV-infection was one of the most important
IRP-parameters [15]. Third, protective antibody titres after
influenza vaccination were reduced in HCMV-positive com-
pared to HCMV-negative elderly individuals, although this
finding was not confirmed in a subsequent study [16,17].
Together, these studies suggest that HCMV-infection may be
associated with decreased immunocompetence of the elderly.
However, it is unclear whether HCMV-infection is causally
linked with accelerated immune senescence or whether it is just
a marker for something else - like poor nutrition during
childhood - since HCMV-infection is known to be associated
with lower socio-economic resources [18]. Moreover, very little
solid information is available about potential underlying
mechanisms of HCMV-induced immune senescence. Immuno-
logically, HCMV-infection is characterised by inducing very
prominent T cell responses with the highest magnitude of all
investigated persistent pathogens, and this response regularly
occupies 20% and more of the total CD8+ T cell pool [19]. In
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addition, T cell responses seem to increase with duration of
infection due to memory inflation both in mice and in humans
[20–25]. This has fostered the hypothesis that these massive
CMV-driven memory T cell expansions significantly accelerate
the age-associated loss of naı¨ve T cells which are indispensible
for potent ‘de novo’ immune responses [26–28]. Others have
speculated that HCMV-infection and HCMV-specific T cells
maintain a proinflammatory cytokine milieu which may be
suppressive for immunity in the elderly [29,30].
Therefore, an animal model for the direct investigation of
CMV-enhanced immune senescence would be extremely infor-
mative 1) to establish a clear link between CMV-infection and
accelerated immune senescence, 2) to quantify the influence of
CMV, 3) to elucidate potential viral and immunological
mechanisms, and 4) to develop intervention strategies for its
prevention. In this study, we have combined mouse (M)CMV
infection with or without thymectomy (Tx) of young adult mice to
generate a model for CMV-enhanced immune senescence. By
performing Tx in mice we aimed to recapitulate the human
situation of a relatively early decline of thymic T cell output [31].
In humans, thymic involution begins shortly after birth and only
a minimal number of new thymic emigrants reach the periphery
in adults, leading to a progressive loss of naı¨ve T cell numbers
and diversity during ageing [32,33]. In mice, the thymus remains
fully functional for prolonged periods of time in relation to their
life expectancy [34].
Our results show that both MCMV-infection and Tx signifi-
cantly decrease antiviral immune responses and protection of
ageing mice. In contrast to Tx, which substantially reduced naı¨ve
T cell numbers over time, MCMV-infection did not measurably
influence the absolute size of the naı¨ve T cell pool. Instead,
MCMV-infection induced a significant and long-lasting expansion
of the total CD8+ T cell compartment by the massive accumu-
lation of effector memory T cells (Tem). Therefore, we propose an
alternative model of CMV-enhanced immune senescence based
on increasing T cell competition. Overall, we present the first data
from a mouse model to confirm that latent CMV-infection itself
has a propagating influence on the development of immune
senescence.
Results
Latent MCMV-infection is associated with impaired viral
control and reduced virus-specific CD8+ T cell immunity
in old mice
To test whether latent MCMV-infection has an influence on
immune control of heterologous viral infections, mice were
infected intravenously (i.V.) with 107 plaque forming units (pfu)
MCMV-D157 at the age of 6–8 weeks. MCMV-D157 is a mutant
virus with a targeted deletion of the MCMV open reading frame
(ORF) m157 encoding a ligand for the NK cell activating receptor
Ly49H [35]. After infection of Ly49H-positive C57BL/6 mice
with MCMV-D157 NK cell stimulation and NK cell mediated
early viral control were substantially attenuated [35]. Moreover,
infection with MCMV-D157 was recently characterised by
increased early antigen load, elevated levels of innate cytokines
but preserved conventional dendritic cell (cDC) function leading to
more robust antiviral CD8+ T cell responses which were
indispensable for termination of productive MCMV-D157 infec-
tion [36]. Since we hypothesised that the magnitude of MCMV-
specific T cell responses was involved in MCMV-enhanced
immune senescence we performed all subsequent experiments
using MCMV-D157 to enhance the probability of a measurable
effect. Despite attenuated NK cell activity, C57BL/6 mice have
usually cleared this virus below the limit of detection in all organs
within 6–8 weeks indicating the establishment of viral latency (data
not shown). Young or old mice with or without latent MCMV-
infection were then infected with different, heterologous viruses
and viral replication and antiviral CD8+ T cell responses were
quantified.
First, we analysed viral control and T cell immunity after
infection with lymphocytic choriomeningitis virus (strain WE;
LCMV-WE), since LCMV elicits a very potent CD8+ T cell
response, which is required for early viral control [37]. It has been
demonstrated before that aged mice are less efficient in mounting
protective LCMV-specific T cell responses [10]. Young (4 or 6
months old; 2 or 4 months after MCMV-infection) and old mice
(15 or 22 months old; 11 or 18 months after MCMV-infection)
with and without latent MCMV-infection were infected i.v. with
26103 pfu of the LCMV-WE. Eight days later, LCMV-titres were
quantified in different organs (Figure 1A, B for lung and spleen;
liver and kidney not shown) and the LCMV-specific CD8+ T cell
response against two immunodominant epitopes derived from the
viral glycoprotein (GP)33 and nucleoprotein (NP)396 was mea-
sured in the blood, spleen and lung by tetramer staining or
intracellular cytokine staining (ICS) (Figure 1C, D for lung). As
shown in figure 1A and B, young mice were able to control
LCMV-replication within 8 days to levels between 1.5–
36103 pfu/organ in spleen and lung, irrespective of latent
MCMV-infection. In parallel, total numbers of GP33- and
NP396-specific CD8+ T cells were comparable in lung
(Figure 1C, D), spleen and blood (data not shown) in MCMV-
infected and MCMV-naı¨ve young mice. These results indicate
that latent MCMV infection does not measurably influence
LCMV replication or LCMV-specific CD8+ T cell responses in
young mice. As expected, LCMV control was affected by age,
since LCMV titres were between 3- and 6-fold higher in old
compared to young mice although the difference did not reach
statistical significance (p = not significant (ns); Figure 1A, B). In
parallel, total numbers of LCMV-specific CD8+ T cells were
between 2- and 3-fold lower in old compared to young mice in all
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Cytomegalovirus (CMV) persistently infects 50–90% of the
human population. After primary infection, constant
immune surveillance is required to prevent CMV-related
disease. During ageing, increasing T cell resources are
expended to keep CMV under control. Recent human
studies have suggested that this investment may come at
the cost of accelerated immune senescence, a condition
describing the age-associated decline of the immune
system’s functionality. In the present study, we have
developed a mouse model to directly investigate whether
and how CMV-infection might impair immunity of aged
individuals. We demonstrate that old mice with long-
lasting CMV-infection are more susceptible to viral
infections than old mice without CMV since their virus
specific T cell response is suppressed. Contrary to the
prevailing hypothesis we found no indication for a CMV-
associated shrinking of the naı¨ve T cell compartment.
Instead, CMV-infection precipitated a massive expansion of
memory T cells. Thus, we propose an alternative mecha-
nism of CMV-enhanced immune senescence based on T
cell competition between CMV-specific memory T cells and
de novo generated T cell responses. In summary, we
provide the first direct evidence that CMV-infection is
indeed a propagating factor for poor immunity in the
elderly.
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Figure 1. LCMV-clearance and LCMV- or VACV-specific CD8+ T cell responses in young and old mice with/without latent MCMV-
infection. A–D: uninfected or MCMV infected (107 pfu MCMV-D157 i.v.) young (4 or 6 months old; 2 or 4 months p.i.) and old (15 or 22 months old;
11 or 18 months p.i.) C57BL/6 mice were infected with 26103 pfu LCMV-WE i.v. Eight days after infection, LCMV titres were determined in spleen (A)
and lung (B) by plaque forming assay and the virus-specific CD8+ T cell response was quantified by ICS in the lung for GP33-specific (C) and NP396-
specific (D) CD8+ T cells. E, F: young (4 months old, 2 months p.i.) and old C57BL/6 mice (25 or 28 months old, 23 or 26 months p.i.) with and without
latent MCMV-infection were infected with 56106 pfu VACV-GP i.p. At the peak of the response on day 6, GP33-specific (E) and B8R-specific (F) CD8+ T
Age, MCMV and Immune Senescence
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organs tested (p = ns; Figure 1C, D for lung; spleen and blood not
shown). These rather small age-associated differences in viral
control and LCMV-specific T cell responses are comparable with
earlier findings from Kapasi et al [10]. More importantly, LCMV
control and LCMV-specific T cell responses were additionally
reduced in old MCMV-infected compared to old MCMV-naı¨ve
mice. Overall, LCMV titres were between 25- and 1,150-fold
higher in old MCMV-infected compared to old MCMV-naı¨ve
mice in spleen (6.76106 vs. 1.76104 pfu/organ, p,0.05), lung
(1.16105 vs. 4.56103 pfu/organ, p,0.05), liver (5.86107 vs.
56104 pfu/organ, p,0.05) and kidney (6.76104 vs.
2.76103 pfu/organ, p,0.1), and between 40- and 2,300-fold
higher compared to young mice, independent of MCMV infection
(spleen p,0.05, lung p,0.05, liver, p,0.05, kidney p,0.1;
Figure 1A, B; data not shown). In parallel, GP33- and NP396-
specific CD8+ T cell responses were about 15-fold (lung) or 3-fold
(spleen) in old MCMV-infected compared to old MCMV-naı¨ve
mice (p = ns; Figure 1C, D; data not shown). Although absolute
numbers of LCMV-specific CD8+ T cells were measurably
reduced in old mice with or without latent MCMV-infection, we
did not identify relevant functional or phenotypic differences
between LCMV-specific CD8+ T cells from these four groups of
mice with respect to cytokine production (IFNc, TNFa),
cytotoxicity measured by degranulation (i.e. CD107a-upregula-
tion) or expression of activation markers like CD43 (not shown).
To corroborate these findings in a different viral model,
similarly treated four groups of young (4 months old) and old
mice (25 or 28 months old) with and without latent MCMV-
infection were prepared and infected intraperitoneally (i.p.) with
56106 pfu of Vaccinia virus (VACV) recombinant for LCMV-GP
(VACV-GP). Six days later, antiviral CD8+ T cell responses were
quantified in the blood, spleen and lung and VACV titres were
measured in the ovaries. Unfortunately, VACV replication could
not be reliably assessed in the ovaries of old and old MCMV-
infected mice since we observed massive differences (up to 105-
fold) of VACV-replication in left and right ovaries of individual
mice and within groups of mice. We suspect that VACV-
replication in ovaries was heavily influenced by individualised
onset of reproductive arrest. However, in young mice, latent
MCMV-infection had no measurable influence on VACV-GP
clearance (data not shown).
Concerning the CD8+ T cell responses, the previous findings
using LCMV were confirmed after VACV-infection since we
recorded similar trends of attenuated T cell responses in old and
latently infected old mice. In young and young MCMV-infected
mice, comparable numbers of CD8+ T cells specific for two out of
three immunodominant VACV-derived epitopes and for the
recombinant LCMV-derived epitope GP33 were recorded at the
peak of the response on day 6 in lung (Figure 1E, F and Figure
S1A, B) and spleen (data not shown). CD8+ T cell numbers were
reduced by a factor of 4 to 14 in old compared to young mice
indicating that ageing also affected T cell immunity after VACV-
GP infection (B8R, A3L, A8R: p,0.01; GP33: p = ns). Compared
to old naı¨ve mice latent MCMV-infection in old mice further
reduced VACV-GP induced CD8+ T cell numbers in the lung and
spleen by a factor of 2.5 to 6 (p = ns for all epitopes and organs;
Figure 1E, F and Figure S1A, B for lung; spleen not shown).
Overall, these data indicate that both ageing and latent MCMV-
infection have a quantitatively comparable influence on antiviral T
cell immunity in old mice. Both effects are modest but consistent
and additive in old mice with latent MCMV-infection.
MCMV control and MCMV-specific CD8+ T cell responses
are not affected by thymectomy
Thymic involution is considered to be a major factor for T cell
based immune senescence in humans [38] but in mice, thymic
involution is considerably delayed in relation to their life
expectancy [31,34]. Therefore, we next investigated whether Tx
of mice at the age of 4–5 weeks would influence and enhance the
development of immune senescence, particularly in the context of
latent MCMV infection. We first tested whether MCMV control
and MCMV-specific immune responses were comparable between
Tx and non-Tx wild type (wt) C57BL/6 mice. Control of lytic
MCMV replication was similar in Tx and wt mice (Figure S2) and
all mice were free of detectable virus in all organs tested and had
thus established latent MCMV-infection within 6–8 weeks after
MCMV-D157 infection (not shown).
We also compared the MCMV-specific CD8+ T cell responses
longitudinally in wt and Tx mice, focussing on M45-specific
CD8+ T cells, which usually display a conventional T cell kinetic
of expansion, contraction followed by low level and stable
memory T cell numbers, and M38-specific CD8+ T cells which
display the phenomenon of memory inflation [20,22,24]. As
shown in Figure 2A, C, memory inflation of M38-specific T cells
occurred mainly during the first three months after infection and
was not influenced by Tx. The apparent increase of M38-specific
T cell frequencies in Tx-mice (Figure 2C, G) was caused by a loss
of total CD8+ T cells after Tx and disappeared in the analysis of
total T cell numbers (Figure 2A, E). Interestingly, despite the
abolished recruitment of new naı¨ve T cells in Tx mice, M38-
specific CD8+ T cells underwent a similar degree of memory
inflation in Tx and wt mice (Figure 2A, C). This confirms earlier
findings, that thymic replenishment of the naı¨ve T cell pool and
the amount of recent thymic emigrants is not crucial for memory
inflation [38,39]. Very advanced age was accompanied by an
impressive loss of the inflated M38-specific CD8+ T cell
population, both in normal and Tx mice (Figure 2C, E, G). This
could indicate that a large proportion of M38-specific memory T
cells were reaching their proliferative limit (Hayflick limit) after
.16 months of MCMV-infection at the age of about 20 months
and that the naı¨ve M38-specific precursors were exhausted as
well. The conventional T cell kinetic of expansion, contraction
and stable memory of the M45-specific CD8+ T cell population
was not significantly influenced by Tx (Figure 2B, D, F, H). M45-
specific cells were stably maintained at low levels well into
senescence with a slight trend for increasing numbers at very old
age (Figure 2D, F) suggesting that these cells and their naı¨ve
precursors were not exhausted.
After immunisation with virus-like particles cellular and
humoral immunity is significantly impaired by ageing
and thymectomy but only marginally by latent MCMV-
infection
To test and compare the impact of age, Tx and MCMV-
infection on cellular and humoral immunity after a potent
cells from the lung were quantified by ICS after in vitro re-stimulation with the respective peptide. Circles indicate total numbers of epitope specific
CD8+ T cells of individual mice, horizontal lines show the medians of an individual group. Data are pooled from two independent experiments.
ANOVA followed by Bonferroni post-analysis was used to determine significant differences between the displayed medians of each group (* p,0.05;
** p,0.01; ns = not significant). The dotted line corresponds to the detection limit of the assay. p.i., post infection.
doi:10.1371/journal.ppat.1002850.g001
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Figure 2. Long-term analysis of MCMV-specific CD8+ T cell responses in thymectomised and non-thymectomised mice. C57BL/6 mice
were thymectomised at age of 4–5 weeks. Two to 3 weeks later, Tx mice (open circles) and non-Tx wild type mice (wt, closed circles) were infected
Age, MCMV and Immune Senescence
PLOS Pathogens | www.plospathogens.org 5 August 2012 | Volume 8 | Issue 8 | e1002850
vaccination approach, mice were immunised with bacteriophage
Qb-derived virus-like particles (VLP) coupled to the LCMV
peptide GP33 (VLP-GP33) and adjuvanted with CpG-oligonucle-
otides [40]. Before immunisation, mice were thymectomised (or
not) at the age of 4–5 weeks and 2–3 weeks later, they were
infected (or not) with 107 pfu MCMV-D157. Three or 15 months
later, all mice were immunised with VLP-GP33 s.c. to induce a
LCMV-GP33-specific CD8+ T cell response. On day 7 after VLP-
immunisation, GP33-specific CD8+ T cell numbers were clearly
reduced in the blood of old mice and of all Tx mice (Figure 3A).
Quantitatively, the effect of 12–15 months older age was
equivalent to Tx at young age and the two effects seemed to be
additive in old Tx mice which displayed the strongest reduction of
GP33-specific T cell numbers after priming with VLP-GP33
(Figure 3A) and more clearly after secondary challenge with
LCMV-WE (see below, Figure 3B). Latent MCMV-infection did
not have a measurable influence on VLP-induced T cell
immunity, since GP33-specific CD8+ T cell numbers were already
at the limit of reliable detection in old and in Tx mice (Figure 3A).
We next investigated, whether reduced priming efficacy after
VLP-GP33 immunisation was associated with decreased T cell
mediated antiviral protection after a challenge with LCMV-WE. On
day 21 after VLP-GP33 immunisation, these eight groups of mice
were infected intravenously with 26103 pfu LCMV-WE. Eight days
later, the GP33-specific CD8+ T cell response was analysed in several
organs, including the lung (Figure 3B). Despite reduced priming
efficiency, the GP33-specific recall CD8+ T cell response after
LCMV-challenge was comparable between aged and young mice in
non-Tx animals. In addition, young Tx mice mounted similar T cell
responses to non-Tx mice. Compared to all other groups, aged Tx
animals had between 10- and 15-fold reduced numbers of GP33-
specific T cells after LCMV-challenge. However, in none of the
tested groups latent MCMV-infection had a measurable influence
on the GP33-specific recall CD8+ T cell response.
We also measured LCMV-titres in spleen, liver, lung and kidney
of these mice. Consistent with the size of the CD8+ T cell
responses, all non-Tx mice had nearly cleared LCMV from all
organs tested including old and old/MCMV-infected mice
(Figure 3C for spleen, 3D for lung; filled symbols). When
comparing LCMV titres after VLP-GP33 immunisation
(Figure 3C, D; filled symbols) with LCMV titres without
immunisation (Figure 1A, B), it is apparent that VLP-GP33
immunisation was highly protective and was able to largely
overcome the age- and MCMV-associated impairment of CD8+ T
cell immunity. However, VLP-GP33 immunisation failed in old
Tx mice, since LCMV titres were between 29- and 1290-fold
increased compared to young Tx mice (p = ns; Figure 3C, D; open
symbols). In addition, old Tx mice with latent MCMV infection
showed a trend to even higher LCMV titres in all tested organs (2-
to 9-fold, p = ns) and thus to reduced protective immunity
compared to old Tx mice. Therefore, VLP immunisation was
not sufficiently protective against a LCMV-challenge in old Tx
mice with and without latent MCMV infection, despite a short
interval after VLP priming and challenge with a low dose of a
LCMV strain with intermediate virulence.
To investigate T help dependent antibody responses in these
eight groups of mice, the Qb-specific IgG-response was measured
10 (Figure 4E) and 20 days (Figure 4F) after VLP-GP33
immunisation. In young mice, Qb-specific IgG-titres were similar
at both time points irrespective of Tx and/or latent MCMV-
infection. In contrast, Tx and ageing clearly and cumulatively
reduced Qb-specific IgG-responses, particularly on day 10 after
immunisation. Qb-specific IgG-titres were between 5- and 15-fold
lower in old/uninfected compared to young/uninfected mice,
irrespective of Tx. On day 20, the age-related differences in
antibody responses were smaller indicating that ageing alone
primarily delayed the response. In contrast, ageing combined with
Tx resulted in a delay and an absolute reduction of the Qb-specific
IgG response. Latent MCMV-infection had a small but consistent
impact on Qb-specific IgG-titres in old mice early after
immunisation (day 10; Figure 3E, p = ns) but not later. Therefore,
latent MCMV-infection is rather delaying than suppressing the
antibody response after VLP-immunisation. Overall, ageing and
Tx clearly reduced the efficacy of VLP-immunisation whereas the
influence of MCMV was very limited.
Expansion of transgenic CD4+ and CD8+ T cells after
VACV-GP infection is not significantly affected by age,
thymectomy and latent MCMV-infection
We next investigated whether CD8+ T cell intrinsic or extrinsic
factors were involved in impaired immune responses of aged, Tx
and MCMV-infected mice. To this end, we co-transferred naı¨ve
TCR-transgenic (tg) CD8+ T cells specific for LCMV-GP33 and
TCR-tg CD4+ T cells specific for LCMV-GP61 from young Ly5.1
positive mice into the eight different groups of Ly5.2 positive
recipient mice mentioned before: young (4–6 months old) or old
(23–28 months old); MCMV-infected (for 2–4 months or 21–24
months) or uninfected; Tx (at 4–5 weeks of age) or no Tx. One day
later, all recipient mice were infected with 56106 pfu VACV-GP
i.p. Donor and recipient derived GP61-specific CD4+ and GP33-
specific CD8+ T cell responses were quantified in the spleen (data
not shown) and in the lung on day 6 after infection. Surprisingly,
expansion of TCR-tg CD4+ and CD8+ T cells was comparable in
all groups of recipient mice, although variability within groups was
increased in old and in Tx mice (Figure 4A, B). This indicates that
MHC class I and class II antigen presentation pathways were
sufficiently functional after VACV-GP-infection irrespective of
ageing, Tx and latent MCMV-infection to allow comparable
expansion of naı¨ve TCR-tg CD4+ and CD8+ T cell populations.
Interestingly, the endogenous GP33 and A8R-specific CD8+ T
cell responses showed the familiar pattern: reduced expansion of
virus specific CD8+ T cells was associated with age, Tx and latent
MCMV-infection (Figure 4C, D) but only differences between
young and old mice were statistically significant. Despite adoptive
transfer of additional and functional LCMV-GP specific TCR-tg
CD4+ T cells the endogenous GP33-specific CD8+ T cell response
was not ‘rescued’ in old, old Tx or old MCMV-infected recipients.
Since the GP33-specific CD8+ T cell response was shown to be T
help dependent after VACV-GP-infection [41], this suggests that
with 107 pfu MCMV-D157 i.v. The MCMV-specific CD8+ T cells were quantified in the blood by tetramer staining and analysed by polychromatic flow
cytometry using beads for direct measurements of total numbers. A–D: longitudinal analysis of the total number of M38- (A) and M45-specific (B)
CD8+ T cells in the blood. Longitudinal analysis of the frequencies of M38- (C) and M45-specific (D) CD8+ T cells in the blood at different time points
after MCMV infection. Circles indicate the mean of 8–11 (A, B) or 5–7 (C, D) mice per group, error bars indicate the SEM. Figure E–H: cross-sectional
analysis of the total numbers (E, F) and the frequencies (G, H) of M38- (E, G) and M45-specific (F, H) CD8+ T cells in the blood of young (3–4 months),
middle-aged (13–18 months) and old C57BL/6 mice (23–28 months). Data of the cross-sectional analysis were pooled from three independent
experiments. ANOVA followed by Bonferroni post-analysis was carried out for calculating significance (* p,0.05; ** p,0.01; *** p,0.001; ns = not
significant). p.i., post infection.
doi:10.1371/journal.ppat.1002850.g002
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Figure 3. Immunogenicity and efficacy of VLP-immunisation against LCMV-challenge in young and old mice with/without Tx or
latent MCMV-infection. Young (5 months old, 3 months p.i.) and old C57BL/6 mice (18 months old, 15 months p.i.) with or without Tx and latent
MCMV-infection were immunised with 10 mg VLP-GP33 s.c. Thereafter, the GP33-specific CD8+ T cell response was measured on day 7 (A) by tetramer
staining and the Qb-specific IgG titres were quantified by ELISA on day 10 (E) and day 20 (F) in the blood. On day 21, all mice were challenged with
26103 pfu LCMV-WE i.v. Eight days after LCMV-challenge the GP33-specific CD8+ T cell response was determined by ICS in the lung (B) and LCMV-
titres were determined in the spleen (C) and in the lung (D) by plaque assay. Circles indicate individual mice, horizontal lines represent the median
(A–D). Vertical bars show the mean of an experimental group, error bars correspond to the SEM (E, F). The dotted line shows the detection limit of the
assay. 4–5 mice per group were included. ANOVA followed by Bonferroni post-analysis was preformed to test for significant differences (* p,0.05; **
p,0.01; ns = not significant).
doi:10.1371/journal.ppat.1002850.g003
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lack of CD4 T cell help was not a major reason for poor CD8+ T
cell expansion in these mice. Overall, our findings are best
explained by an intrinsic defect of the endogenous CD8+ T cell
population to expand after cognate antigen encounter due to
ageing, Tx and MCMV-infection.
Impact of age, thymectomy and MCMV-infection on the
size and composition of the CD8+ T cell compartment
To further investigate the mechanisms behind impaired T cell
immunity in the context of ageing, thymic involution (i.e. Tx) and
MCMV-infection we performed a detailed quantitative analysis of
the impact of these three parameters on the composition of the
peripheral T cell pools. There is compelling evidence from human
studies that HCMV-infection leaves a unique signature on the
CD8+ T cell compartment but less so for the CD4+ T cell
compartment [26–28]. We first analysed the CD8+ T cell
compartment in the blood of young (3–4 months), middle-aged
(13–18 months) and old mice (23–28 months) with/without Tx
and latent MCMV-infection, respectively (Figure 5).
MCMV-infection of young mice resulted in a substantial
expansion of the total CD8+ T cell compartment irrespectively
of Tx and this difference was maintained during ageing
(Figure 5A). Independently of MCMV-infection or Tx, there
was an age-associated decline of the total CD8+ T cell pool.
Finally, Tx initially reduced the size of the total CD8+ T cell pool
in young and young MCMV-infected mice, but this difference
gradually disappeared over time.
Several human studies have demonstrated that HCMV
infection is associated with a sizeable reduction of the naı¨ve
CD8+ T cell pool, although most of these studies recorded T cell
frequencies and not total numbers [26,28]. Indeed, our results
Figure 4. Analysis of virus specific T cell responses after adoptive transfer of TCR transgenic CD8+ and CD4+ T cells and VACV-GP
infection in young and old mice with/without Tx or latent MCMV-infection. Transgenic GP33-specific CD8+ and GP61-specific CD4+ T cells
were isolated from the spleen of young Ly5.1+ donor mice and transferred into young (4–6 months old) or old (23–28 months old), MCMV-infected
(2–4 or 20–25 months p.i.) or uninfected, Tx (open circles) or non-Tx (wt, closed circles) recipients (Ly5.2). One day later, mice were infected with
56106 pfu VACV-GP i.p.. Six days later, VACV-GP-specific CD4+ and CD8+ T cell responses were measured in the lung by tetramer-staining (A) or by ICS
after in vitro re-stimulation with the respective peptide (B–D) and analysed by flow cytrometry. (A) Total number of GP33-specific transgenic CD8+ T
cells (Ly5.1) in the lung. (B) Total number of GP61-specific transgenic CD4+ T cells (Ly5.1) in the lung. (C) Total number of endogenous GP33-specific
CD8+ T cells (Ly5.2) in the lung. (D) Total number of endogenous A8R-specific CD8+ T cells in the lung. Pooled data from two independent
experiments are displayed. Circles indicate values of individual mice, horizontal bars indicate the medians. Significance was assessed by ANOVA
followed by Bonferroni post-analysis (* p,0.05; ** p,0.01; ns = not significant).
doi:10.1371/journal.ppat.1002850.g004
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Figure 5. Long-term analysis of the CD8+ T cell compartment after MCMV infection and/or thymectomy in young, middle-aged and
old mice. C57BL/6 mice were thymectomised at age of 4–5 weeks. Two to 3 weeks later, Tx (right panel) and non-Tx wild type (WT, left panel) mice
were infected with 107 pfu MCMV-D157 i.v. The absolute number of CD8+ T cells was quantified in the blood and phenotypically characterised by
polychromatic flow cytometry using CD44 and CD62L. Quantitative analysis of total CD8+ T cell numbers (A), naı¨ve CD8+ T cell numbers (B;
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confirm that MCMV-infection is associated with an immediate
and pronounced reduction of naı¨ve CD8+ T cell frequencies
comparable to human studies (Figure S3A). To our surprise,
absolute numbers of naı¨ve CD8+ T cells were similar in the blood
of uninfected and MCMV-infected mice (Figure 5B). These data
were confirmed in another cohort of 8 and 13 months old mice,
where absolute naı¨ve CD8+ T cell numbers were not reduced by
latent MCMV-infection in non-lymphoid (lung, blood) and in
secondary lymphoid organs (spleen, cervical and inguinal lymph
nodes, Figure 6A). In contrast, ageing and Tx clearly and
cumulatively reduced the total naı¨ve CD8+ T cell pool leaving
very few naı¨ve T cells in old Tx mice. We suspect that the
apparent increase of naı¨ve T cells in old/Tx/MCMV-infected
mice (Figure 5B, right panel, right column) might be caused by a
poor discrimination of CD44-high and CD44-low T cell
populations in this group of mice.
In contrast to the naı¨ve T cell pool, MCMV-infection induced a
massive (.10-fold) expansion of blood CD44+ CD62L2 effector
memory (Tem) CD8+ T cells in young mice independent of Tx
(Figure 5C). During ageing, Tem-numbers slowly increased in
uninfected and uninfected Tx mice and remained stable in
MCMV-infected mice. Although the impact of MCMV-infection
on Tem differences gradually dwindled with increasing age, Tem-
numbers were consistently and significantly increased by MCMV-
infection across all age groups, whereas Tx had no significant
influence. Tem-numbers were also significantly increased in the
lung and spleen of MCMV-infected mice whereas numbers were
comparable to MCMV-naı¨ve mice in both sets of lymph nodes
(Figure 6B).
Contrary to Tem, the CD44+ CD62L+ central memory (Tcm)
CD8+ T cell pool was not measurably altered by MCMV-infection
in blood, lung, spleen or lymph nodes (Figure 5D and 6C). In
addition, neither ageing nor Tx had a measurable influence on
absolute numbers of blood Tcm (Figure 5D). In summary, ageing
and Tx mainly reduced the naı¨ve CD8+ T cell pool whereas
MCMV-infection had surprisingly little influence on naı¨ve T cell
numbers but massively boosted the Tem pool. These additional T
cells were accommodated in the CD8-compartment by a long
lasting expansion of the total CD8+ T cell pool in MCMV-infected
mice and not by a reduction of the naı¨ve T cell pool.
Impact of age, thymectomy and MCMV-infection on the
size and composition of the CD4+ T cell compartment
The total CD4+ T cell compartment was not significantly
altered by MCMV-infection (Figure 7A) although, there was a
trend to increased CD4+ T cell numbers in Tx mice with latent
MCMV-infection. In contrast, both age and Tx significantly and
cumulatively reduced the total CD4+ T cell pool. Similarly, latent
MCMV-infection did not measurably influence the total number
of naı¨ve CD4+ T cells in the blood (Figure 7B) or in different
lymphoid and non-lymphoid organs (Figure 6D). Ageing was
associated with a progressive but gradual loss of naı¨ve T cell
numbers whereas the very prominent Tx-associated reduction
appeared within 6 months after Tx, leading to a .30-fold drop of
naı¨ve CD4+ T cell numbers from young to middle-aged mice
(Figure 7B).
In the memory compartment, latent MCMV-infection also led
to a slight expansion of blood CD4+ Tem but not of Tcm in young
mice and this difference was partially maintained for Tem during
ageing (Figure 7C, D). However, in lung, spleen and lymph nodes
CD4+ Tem and Tcm numbers were similar in MCMV-infected
and MCMV-naı¨ve mice (Figure 6E, F). Ageing and Tx only had a
minimal influence on the total number of CD4+ Tem (Figure 7C).
Ageing led to a gradual and progressive reduction of CD4+ Tcm in
normal mice whereas this process was accelerated in Tx-mice
leading to low Tcm numbers already in middle-aged mice
(Figure 7D). Overall, the effects of MCMV-infection on the
CD4-compartment were much more subtle but similar to CD8 as
an overall trend, whereas Tx had a more profound and immediate
impact on the total and the naı¨ve CD4 compartment.
Discussion
Our data demonstrate for the first time in a mouse model that
long-term latent MCMV-infection interferes with the induction of
protective immunity in aged mice. Latent MCMV-infection
additively impaired the poor control of LCMV-infection in old
mice and this loss of antiviral protection was linked to reduced
expansion of LCMV-specific CD8+ T cells. Moreover, latent
MCMV-infection was associated with decreased CD8+ T cell
expansions in old mice after infection with VACV but not after
VLP-immunisation. Nevertheless, protective efficacy of VLP-
immunisation against LCMV-challenge was impaired in old Tx
mice with latent MCMV-infection. These data from a variety of
infectious and non-infectious experimental models establish a
causal role of latent MCMV-infection as a propagating factor for
poor immunity in old age contributing to T cell based immune
senescence. Our data are strongly corroborated by similar results
from Cicin-Sain et al., who found reduced CD8+ T cell responses
after superinfection with Influenza virus, West Nile virus (WNV)
and Herpes simplex virus Type 1 in old mice with latent MCMV-
infection [42].
At first glance our findings seem to contradict an earlier study
demonstrating partial protection against bacterial challenge in
mice recently infected with MCMV or murine herpesvirus-68 by
activated innate immune responses [43]. Although our study
primarily focused on the impact of long-lasting latent MCMV-
infection on T cell immunity in old mice, where we demonstrate
impaired T cell mediated antiviral protection in latently infected
mice, we have neither seen any protective effect of MCMV-
infection against LCMV or VACV in young mice (Figure 1A, B;
VACV not shown). These discrepancies are most likely explained
by differences in challenge systems: while Barton et al. used
bacterial pathogens (i.e. Listeria and Yersinia) [43] we and Cicin-
Sain have applied viral challenges [42]. Alternatively, partial
protection by activated innate immune mechanisms may have
been counteracted by impaired adaptive immunity in young mice
with latent MCMV-infection.
Our findings in this experimental mouse model strongly support
previous observational human studies suggesting that HCMV-
infection may be associated with accelerated immune senescence
[12]. This notion was largely based on longitudinal cohort studies
and cross-sectional epidemiological studies demonstrating a
significant association of HCMV-seropositivity with decreased
survival of very elderly [13–15]. Moreover, HCMV-infection was
associated with reduced immunogenicity of influenza vaccination
CD8+CD442CD62L+), effector memory (Tem) CD8+ T cell numbers (C; CD8+CD44+CD62L2) and central memory (Tcm) CD8+ T cell numbers (D;
CD8+CD44+CD62L+). Data were pooled from three independent experiments. Circles indicate values of individual mice, horizontal bars correspond to
the median of an experimental group. Significance was assessed by ANOVA followed by Bonferroni post-analysis (* p,0.05; ** p,0.01; *** p,0.001;
ns = not significant).
doi:10.1371/journal.ppat.1002850.g005
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in elderly [17] although this was not confirmed more recently [16].
Interestingly, immunogenicity of CpG-adjuvanted VLPs was
sufficient to largely overcome the age- and MCMV-associated
immune attenuation in our experimental model (Figure 3). Only
very old Tx mice with particularly low naı¨ve T cell counts before
VLP-immunisation were not protected against a LCMV-challenge
(Figure 3C, D) This may indicate that more immunogenic vaccines
than those currently available for influenza could help to improve
protective immunity in the subset of elderly with a minimally
maintained naı¨ve T cell repertoire.
All of the above mentioned human studies about the impact of
naturally acquired HCMV-infection on waning immunity in the
elderly are limited by the fact that a variety of factors may strongly
influence any significant association. Potential confounders include
1) individual characteristics of HCMV-infection like virus isolate,
dose, route, time point and severity of primary infection and the
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Figure 6. Alterations of CD4+ and CD8+ T cell populations in secondary lymphoid and non-lymphoid organs of middle-aged mice
with (open symbols) and without (closed symbols) latent MCMV-infection. Half of the mice were infected with 107 pfu MCMV-D157 i.v. at
the age of 8 weeks. At the age of 8 (triangles) or 13 (circles) months, blood was taken, mice were perfused and sacrificed and total numbers of naı¨ve
(CD442CD62L+) CD8+ (A) and CD4+ (D) T cells, effector memory (Tem; CD44+CD62L2) CD8+ (B) and CD4+ (E) T cells and central memory (Tcm;
CD44+CD62L+) CD8+ (C) and CD4+ (F) T cells were determined in different organs by polychromatic flow cytometry using bead calibration. Absolute
numbers of T cells are given for blood, lung, spleen, cervical (cer) and inguinal (in) lymph nodes (LN). Circles indicate values of individual mice,
horizontal bars correspond to the median of an experimental group. Significance was assessed by t-test (* p,0.05; ** p,0.01; *** p,0.001; ns = not
significant).
doi:10.1371/journal.ppat.1002850.g006
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Figure 7. Long-term analysis of the CD4+ T cell compartment after MCMV infection and/or thymectomy in young, middle-aged and
old mice. C57BL/6 mice were thymectomised at age of 4–5 weeks. Two to 3 weeks later, Tx (right panel) and non-Tx wild type (WT, left panel) mice
were infected with 107 pfu MCMV-D157 i.v. The absolute number of CD4+ T cells was quantified in the blood and phenotypically characterised by
polychromatic flow cytometry using CD44 and CD62L. Quantitative analysis of total CD4+ T cell numbers (A), naı¨ve CD8+ T cell numbers (B;
CD4+CD442CD62L+), effector memory (Tem) CD4+ T cell numbers (C; CD4+CD44+CD62L2) and central memory (Tcm) CD4+ T cell numbers (D;
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frequency of re-infection or re-activation, 2) genetic variability of
the host directing the antiviral immune response, 3) general health
and socio-economic situation of the host both presently and in the
past (co-morbidities, medication, nutrition, living conditions,
physical activity, health seeking behaviour a.s.o.), and 4) the host’s
past infectious history apart from HCMV. For obvious reasons, it
is impossible to control for most of these parameters in human
studies. In contrast, we were able to exclude or balance these
confounders in our mouse model. Therefore, our data provide the
most direct evidence that CMV-infection itself is the driving force
for the association between CMV-infection and impaired immu-
nity in aged hosts.
Concerning the major mechanism of CMV-enhanced immune
senescence, most experts in the field favour the concept that
CMV-driven memory T cell accumulations progressively restrict
the size and the diversity of the naı¨ve T cell pool, thus
exacerbating the age associated alterations of the T cell
compartment [44]. Studies in old mice and macaques have clearly
established that both size and diversity of the naı¨ve T cell pool are
crucial for maintenance of immune protection [11,45]. Indeed,
several human studies have shown that naı¨ve CD8+ T cell
frequencies in the blood were significantly reduced in HCMV-
infected elderly or thymectomised young adults [26,28,46] but
only few studies have reported significant reductions of absolute
naı¨ve CD8+ T cell numbers [27]. Our data demonstrate that total
numbers of naı¨ve CD4+ and CD8+ T cells were not significantly
reduced by MCMV-infection in blood, spleen, lymph nodes and
lung. This argues against the currently favoured hypothesis that
CMV-infection reduces the number of available naı¨ve T cells. At
present, we cannot formally exclude the possibility of MCMV-
dependent qualitative alterations of the naı¨ve T cell pool,
especially concerning repertoire diversity.
Since adoptively transferred CD4+ and CD8+ T cells displayed
comparable immune responses in all recipients irrespective of ageing,
thymectomy and MCMV-infection, our results are best explained by
a deficient activation and/or expansion of the endogenous T cell
population (Figure 4). Indeed, Cicin-Sain et al were able to
demonstrate an inhibitory effect of latent MCMV-infection on T
cell recruitment and/or activation exclusively in draining lymph
nodes after intranasal Influenza infection [42]. Our data further
suggest that MHC class I and class II dependent antigen presentation
was not substantially altered by ageing, thymectomy or latent
MCMV-infection to interfere with activation and expansion of tg
CD4+ and CD8+ T cells after VACV-infection. This is in line with
similar antigen presentation in young and old monkeys after Vaccinia
immunisation [45]. Although productive MCMV-infection has been
shown to severely impair DC function [47] our results argue against a
major interference of latent MCMV-infection with overall function-
ality of DCs as an explanation for reduced heterologous antiviral
immunity: 1) Latent MCMV-infection of young mice was not
associated with any measurable reduction of T cell immunity. 2)
Activation, expansion and functionality of adoptively transferred
naı¨ve transgenic CD4+ and CD8+ T cells were comparable in all
hosts tested, irrespective of MCMV-infection, age and Tx (Figure 4A,
B). 3) Latent MCMV-infection did not significantly impair the
primary CD8+ T cell response after VLP-GP33 immunisation in old
mice (Figure 3A) although protective efficacy was eventially reduced
in MCMV-infected old Tx mice (Figure 4C, D). Moreover, Cicin-
Sain et al show that latent MCMV-infection with a mutant virus
deficient for critical immune evasive genes was still associated with
poor WNV-specific T cell immunity [42]. Lastly, it is unlikely that
limiting T cell help was a major factor for MCMV-infection
associated immune failure in our experimental setup. Provision of
additional T cell help by adoptive transfer of tg CD4+ T cells was not
sufficient to rescue the poor endogenous CD8+ T cell response in old,
Tx and MCMV-infected mice although CD8+ T cell expansion after
VACV-GP infection is known to be help dependent [41].
As opposed to the naı¨ve T cell compartment, there is compelling
evidence in mice, macaques and humans that CMV-infection
drastically increases the memory T cell pool, particularly
regarding CD8+ Tem [19,25–28,48–53]. Interestingly, those
human studies indicating an association of HCMV-infection with
poor vaccine immunogenicity or with reduced survival of very
elderly, have also reported an association with CD8+ Tem
expansions and not with a reduction of naı¨ve T cells [15,17].
Similarly, the correlation of poor T cell expansion after
heterologous WNV infection was stronger for increased Tem
than for reduced naı¨ve T cells in the MCMV-model [42].
Therefore, data from the MCMV-model support the human
findings and demonstrate a vigorous expansion of Tem after
MCMV-infection which was maintained into old age by memory
inflation. MCMV-dependent Tem accumulation caused a signif-
icant and long lasting expansion of the total CD8+ T cell pool
without restricting the available immunologic ‘space’ for naı¨ve T
cells explaining the discrepancy between reduced frequencies but
maintained total numbers of naı¨ve T cells after MCMV-infection
(Figure 5B, S3A). This highlights the fact that the CD8+ T cell
compartment has considerable plasticity and can grow in size
according to the cumulative antigen experience of the host [54].
Based on these findings, we postulate that CMV-dependent
CD8+ Tem expansion is more important for CMV-enhanced
immune senescence than naı¨ve T cell suppression. Moreover, we
would like to propose a model of enhanced competition for
immunologic niches and survival factors between pre-existing
CMV-specific memory T cells and newly generated effector T cells
after heterologous infection or immunisation (Figure 8). CMV
maintains memory T cells at very high frequencies well into old
age, preferentially in the CD8+ T cell compartment as Tem, which
persistently occupy critical niches both within secondary lymphoid
(i.e. spleen) and peripheral organs. At first glance, the absence of
Tem accumulations in lymph nodes of MCMV-infected mice
(Figure 6C, D) may contradict a competitive model. However,
Torti et al have recently shown that MCMV-specific inflationary
T cells maintain a Tcm phenotype in lymph nodes where they
interact with antigen presenting cells of non-hematopoietic origin
and then egress the lymph nodes probably as Tem [55].
Therefore, competition of expanded MCMV-specific memory T
cell populations with newly generated effector cells after heterol-
ogous infection or immunisation may still take place within, on the
way out or even outside lymph nodes. Of note, we find the most
robust differences in T cell immunity after systemic LCMV-
infection (Figure 1A–D), where T cell competition may preferen-
tially occur in the spleen and not in lymph nodes. Moreover,
LCMV-infection induces a massive inflammatory response which
has the potential to trigger MCMV-reactivation. If this occurs
expanded CMV-specific memory T cell populations are not only
induced by bystander activation but also directly by TCR-
mediated signals leading to further memory inflation and
potentially to enhanced competition with heterologous T cell
responses. However, our hypothesis of enhanced T cell compe-
CD4+CD44+CD62L+). Data were pooled from three independent experiments. Circles indicate values of individual mice, horizontal bars correspond to
the median of an experimental group. Significance was assessed by ANOVA followed by Bonferroni post-analysis (* p,0.05; ns = not significant).
doi:10.1371/journal.ppat.1002850.g007
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tition needs to be tested in future studies together with a detailed
analysis of the naı¨ve T cell repertoire in old mice with and without
latent MCMV-infection, since the absolute number of naı¨ve
precursor T cells is most likely to be CMV-independent but
nevertheless crucial for maintained immunity in aged hosts. This is
suggested by our findings of comparable T cell immunity in latently
infected young mice, where the T cell repertoire was not yet affected
by ageing or Tx, and supported by the comparable expansion of tg
T cells irrespective of age, MCMV-infection or Tx, where we
artificially increased and normalized the naı¨ve precursor frequency.
In summary, our results demonstrate that MCMV-infection has
a moderate but significant negative influence on antiviral immune
responses and protective immunity in old mice. However, Tx at
young age and ageing itself seem to restrict immunity more
profoundly than MCMV-infection. The involved mechanisms are
likely to be different since ageing and Tx operate via the restriction
of the naı¨ve T cell pool while latent MCMV infection leaves the
naı¨ve T cell pool untouched but mainly propagates memory and
total T cell expansions (Figure 8). Our model of latent MCMV-
infection with or without Tx seems to be well suited to further
investigate the underlying mechanisms and to develop and test
preventive strategies. Finally, our results strongly support previous
human studies that have found an association of CMV-infection
with declining immunity in old age [12]. Since we and others were
able to demonstrate a similar association in a very well controlled
mouse model [42] there is now solid evidence that latent CMV-
infection is a propagating factor for immune senescence in mice
and in humans.
Materials and Methods
Ethics statement
This study was carried out in strict accordance to the guidelines of
the animal experimentation law (SR 455.163; TVV) of the Swiss
Federal Government. The protocol was approved by Cantonal
Veterinary Office of the canton of Zurich, Switzerland (Permit
number 174/2006 and 158/2010). Surgery was performed under
isoflurane anesthesia and all efforts were made to minimize suffering.
Mice
C57BL/6 mice were purchased from Jackson Laboratory
(Germany) and Charles River (Germany) and were kept under
specific pathogen free (SPF) conditions throughout the study.
Transgenic mice expressing the TCR specific for the LCMV-GP
derived CD8+ T cell epitope GP33 (P14 mice) and mice expressing
the TCR specific for the LCMV-GP derived CD4+ T cell epitope
GP61 (Smarta mice) were provided by Prof. A. Oxenius (ETH
Zurich, Switzerland) [56,57]. C57BL/6 mice were thymectomised
at 4–5 weeks of age by vacuum extraction of the thymus along the
trachea. Mice were anesthetized with isoflurane during the
procedure and received analgesia with Buprenorphin i.p. from
day -1 until day 6 after Tx. They entered the experiment after a
recovery period of 2–3 weeks.
Viruses and virus like particles
All viruses were provided by Prof. A. Oxenius (Zurich,
Switzerland). The recombinant MCMV-D157 is a deletion mutant
Figure 8. Integrative model of the influence of MCMV-infection, ageing and thymectomy on CD8+ T cell populations and protective
immunity. Ageing is accompanied by a slow but progressive decline of the total (black line) and the naı¨ve (red line) CD8+ T cell pool. Immune
senescence is characterised by an age-associated reduction of immunocompetence (blue line), particularly against newly encountered antigens (e.g.
LCMV). Tx of young mice leads to a substantial and rapid shrinking of the naı¨ve T cell compartment reducing the number and the diversity of naı¨ve T
cell precursors on top of ageing. Tx also reduces the total CD8+ T compartment, which is later affected by an age-associated decline. MCMV-infection
results in an immediate and persistent expansion of the total CD8+ T cell compartment whereas the naı¨ve T cell pool remains intact. Nevertheless,
MCMV-infection contributes to reduced immunocompetence over time, possibly by an enhanced competition of massively expanded CMV-specific
Tem with newly generated effector cells. In old Tx mice with latent MCMV-infection, immuocompetence is cumulatively affected by the restricted
naı¨ve T cell pool and by the increased competition of CMV-specific Tem.
doi:10.1371/journal.ppat.1002850.g008
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of MCMV lacking the m157 ORF leading to decreased NK-cell
control in C57BL/6 mice [58]. The mutant virus was originally
generated according to the published method using the bacterial
artificial chromosome BAC pSM3fr [59]. MCMV was propagated
on mouse embryonic fibroblasts (MEFs) and virus titres of virus
stocks and organ homogenates were determined by plaque assays
on MEFs as previously described, using centrifugal enhancement
of infectivity and an adapted Avicel overlay (3% Avicel, 10%
MEM, 10% FCS, 200 mM Glutamine, penicillin, streptomycin,
10 mM HEPES/NaHCO3, H2O) [60]. Mice were infected with
107 pfu of MCMV-D157 at the age of 6–10 weeks. LCMV-WE
was propagated on L929 fibroblast cells. LCMV titres were
determined by a virus focus forming assay on MC57G fibroblasts
as previously described [61]. Mice were infected with 26103 pfu
LCMV-WE i.v. at the indicated time points. VACV-GP was
propagated and plaqued on BSC40 cells. Mice were infected with
56106 pfu VACV-GP i.p. at the indicated time points. The virus
like particles VLP-GP33 were composed of the core protein of the
Qb-bacteriophage, coupled with the LCMV derived GP33-
peptide, packaged with CpG oligonucleotides (59-
GGGGTCAACGTTGAGGGGGG-39, thioester stabilized) and
produced as previously described [40]. Mice were immunized with
200 mg VLP-GP33 s.c. into the flank at the indicated time points.
The VLPs were provided by Dr. M. Bachmann (Cytos Biotech-
nology, Schlieren, Switzerland).
Adoptive transfer
Adoptive transfer experiments were performed with cells
isolated from spleens of tg Ly5.1-positive P14 or Smarta mice
into Ly5.2 positive recipients to allow for simple discrimination of
their origin by FACS. Using CD8 or CD4-beads, TCR-tg CD8+
or CD4+ T cells were purified by MACS from donor P14 mice or
Smarta mice, respectively. 104 naı¨ve tg CD8+ and CD4+ T cells
were mixed and co-transferred i.v. into naı¨ve or MCMV-infected
recipient mice. One day later, mice were infected with 56106 pfu
VACV-GP i.p. and responses were analysed after six days.
Isolation of murine lymphocytes from solid organs
Infected or uninfected mice were anesthetized i.p. with an
anaesthetic cocktail containing Xylazin (Rompun), Ketamin
(Ketasol) and Acepromazin (Prequillan). After the surgical level
of anaesthesia was reached mice were perfused with 5–10 ml of
cold PBS to remove all contaminating blood from the organs.
Organs were collected, cut into small pieces and digested by
incubating for 20 min at 37uC with 3 ml of an enzyme cocktail
(x100 stock: 2.4 mg/ml collagenase and 0.2 mg/ml DNAse
dissolved in RPMI medium with 10% FCS). After gentle
mechanical tissue disruption by pulling the sample through an
18 G needle and additional 20 min incubation with 2 ml of fresh
enzyme cocktail the sample was pushed through a cell strainer and
centrifuged. After a Percoll gradient centrifugation to isolate viable
lymphocytes the cells were washed twice, counted and resus-
pended in RPMI 10% FCS for further analysis. Single cell
suspensions of spleen cells were produced by gently pressing the
organ trough a grid of stainless steel with a plug. Viable cells were
counted by trypan blue exclusion using Neubauer counting
chambers.
Antibodies and tetramers
Monoclonal antibodies for flow cytometry assays were purchased
from Becton Dickinson (Switzerland) or BioLegend (Switzerland).
The following antibodies were used: anti-CD8-Pacific Blue/PerCp
(clone 53-6.7), anti-CD4-PE (clone RM4–5), anti-CD44-PE-Cy7
(clone IM7), anti-CD62L-FITC (clone MEL-14), anti-IFNc-APC/
PE-Cy7 (clone XMG1.2), and anti-CD45.1-PE (Ly5.1) (clone A20).
M38-/M45-specific (MCMV) and GP33-specific (LCMV)
CD8+ T cells were detected by MHC class I tetramer staining
using APC-conjugated tetramers. Tetramers were produced as
previously published [62].
Immunofluorescence staining and analysis
50–100 ml of blood or 106 cells isolated from spleen or lung were
stained with fluorochrome conjugated monoclonal antibodies for
20 min at 4uC. Tetramer staining was performed for 20 min at
4uC or 37uC. Using BD FACS Lysing Solution cells were fixed for
10 min at RT. After a washing step, conjugated antibodies were
added to the cells for 20 min at 4uC and cells were washed and
resuspended in 200 ml FACS buffer for analysis (PBS, 5 mM
EDTA, 2% FCS, 0.05% NaN3). Samples were measured with a 6
or 8 colour BD FACS Canto II Flow Cytometer using FACS Diva
software. The data files were analysed with Flowjo version 7.5.2.
Calibration with beads was used to measure and calculate total cell
numbers.
Peptides and in vitro stimulation of CD8+ T cells
MCMV derived peptides M45985–993 (HGIRNASFI, H2-D
b)
and M38316–323 (SSPPMFRV, H2-K
b), LCMV-derived peptide
GP3333–41 (KAVYNFATC, H2-D
b), NP396396–404
(FQPQNGQFI, H2-Db) and Vaccinia derived peptides B8R20–27
(TSYKFESV, H2-Kb), A3L270–277 (KSYNYMLL, H2-K
b) and
A8R189–196 (ITYRFYLI, H2-K
b) were purchased from EMC
Microcollections (Tu¨bingen, Germany). Cytokine production of
activated cells was detected by intracellular cytokine staining.
26106 tissue lymphocytes or splenocytes were stimulated with
1026 M specific peptide for 5–6 h at 37uC in the presence of
Monensin (2 mM) or/and Brefeldin A (10 mg/ml). Cells were then
washed with FACS buffer and stained for cell surface markers for
20 min at 4uC. Cells were fixed and permeabilized with BD FACS
Lysing Solution (1:5 dilution, 0.05% Tween20) for 10 min at RT
and washed with FACS buffer. Cytokine specific antibodies were
added to the cells for 20 min at 4uC. After washing cells were
resuspended into 200 ml PBS with 1% paraformaldehyde and
acquired with a FACS Canto II cytometer.
ELISA
Qb-specific IgG antibodies were quantified by ELISA as
previously described [63].
Statistical analysis
One-way ANOVA followed by Bonferroni post-analysis was
used for group comparisons using Graph Pad Prism (GraphPad
Software, La Jolla, CA). The p-values are indicated in the graphs
(*,0.05, ** p,0.01, *** p,0.001).
Supporting Information
Figure S1 A3L and A8R-specific T cell responses after VACV-
GP33-infection of young and old mice with and without latent
MCMV-infection. Young (4 months old, 2 months p.i.) and old
C57BL/6 mice (25 months old, 23 months p.i.) with and without
latent MCMV-infection were infected with 56106 pfu VACV-GP
i.p. At the peak of the response on day 6, A3L-specific (A) and
A8R-specific (B) CD8+ T cells from the lung were quantified by
ICS after in vitro re-stimulation with the respective peptide. Circles
indicate total numbers of epitope specific CD8+ T cells of
individual mice, horizontal lines show the medians of an individual
group. ANOVA followed by Bonferroni post-analysis was used to
Age, MCMV and Immune Senescence
PLOS Pathogens | www.plospathogens.org 15 August 2012 | Volume 8 | Issue 8 | e1002850
determine significant differences between the displayed medians of
each group (* p,0.05; ** p,0.01; *** p,0.001; ns = not
significant).
(EPS)
Figure S2 MCMV control in thymectomised mice. C57BL/6
mice were thymectomised at age of 4–5 weeks. Two to 3 weeks
later, Tx and non-Tx wild type (WT) mice were infected with
107 pfu MCMV-D157 i.v. Eight days after MCMV infection viral
titres were determined by plaque assay in salivary glands (SG),
spleen, lung and liver. One of two similar experiments is shown.
Circles indicate values of individual mice, horizontal bars
correspond to the median of an experimental group. T-test was
used to determine significant differences between the displayed
medians of respective groups (ns = not significant).
(EPS)
Figure S3 Long-term analysis of naı¨ve CD4+ and CD8+ T cell
frequencies after MCMV infection and/or thymectomy in young,
middle-aged and old mice. C57BL/6 mice were thymectomised at
age of 4–5 weeks. Two to 3 weeks later, Tx (right panel) and non-
Tx wild type (WT, left panel) mice were infected with 107 pfu
MCMV-D157 i.v. The frequencies of naı¨ve CD8+ and CD4+ T
cells were quantified in the blood by polychromatic flow cytometry
using CD44 and CD62L. Frequencies of naı¨ve CD442, CD62L+
CD8+ (A) and CD4+ (B) T cells are shown. Data from three
independent experiments also shown in Figure 5 and 7 were
pooled. Circles indicate values of individual mice, horizontal bars
correspond to the median of an experimental group. Significance
was assessed by ANOVA followed by Bonferroni post-analysis (*
p,0.05; *** p,0.001; ns = not significant).
(EPS)
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